Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01494792 · ClinicalTrials.gov registry record
Sofia Strep A FIA Field Study
A clinical trial, sponsored by Quidel Corporation.
- Terminated
- Registry status
- 2,090
- Enrollment target
NCT01494792 is a clinical trial that was terminated before completion, run by Quidel Corporation. The registered enrollment target is 2,090 participants.
The verdict
NCT01494792 was terminated before completion, sponsored by Quidel Corporation.
- TERMINATED
- Registry status
- 2,090 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.
Interventions
- DEVICE In Vitro Diagnositc aid for diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,090 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01494792
The ClinicalTrials.gov registry entry for NCT01494792 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2,090 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which In Vitro Diagnositc aid for diagnosis is the first listed.
NCT01494792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01494792 about?
NCT01494792 is a clinical study titled "Sofia Strep A FIA Field Study". The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.
What is the current status of trial NCT01494792?
This trial is currently terminated. The enrollment target is 2,090 participants. The study started on 2011-11. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01494792?
The interventions under investigation include: In Vitro Diagnositc aid for diagnosis (DEVICE).
Who is sponsoring clinical trial NCT01494792?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.